192 related articles for article (PubMed ID: 9425421)
1. Chromatic-contrast threshold impairment in diabetes.
Tregear SJ; Knowles PJ; Ripley LG; Casswell AG
Eye (Lond); 1997; 11 ( Pt 4)():537-46. PubMed ID: 9425421
[TBL] [Abstract][Full Text] [Related]
2. Colour vision in diabetic and normal pseudophakes is worse than expected.
Knowles PJ; Tregear SJ; Ripley LG; Casswell AG
Eye (Lond); 1996; 10 ( Pt 1)():113-6. PubMed ID: 8763315
[TBL] [Abstract][Full Text] [Related]
3. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy.
Greenstein V; Sarter B; Hood D; Noble K; Carr R
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1008-14. PubMed ID: 2354907
[TBL] [Abstract][Full Text] [Related]
4. Colour contrast sensitivity in patients with age-related Bruch's membrane changes.
Holz FG; Gross-Jendroska M; Eckstein A; Hogg CR; Arden GB; Bird AC
Ger J Ophthalmol; 1995 Nov; 4(6):336-41. PubMed ID: 8751098
[TBL] [Abstract][Full Text] [Related]
5. Loss of chromatic sensitivity in AMD and diabetes: a comparative study.
O'Neill-Biba M; Sivaprasad S; Rodriguez-Carmona M; Wolf JE; Barbur JL
Ophthalmic Physiol Opt; 2010 Sep; 30(5):705-16. PubMed ID: 20883358
[TBL] [Abstract][Full Text] [Related]
6. Screening for sight-threatening diabetic retinopathy: comparison of fundus photography with automated color contrast threshold test.
Ong GL; Ripley LG; Newsom RS; Cooper M; Casswell AG
Am J Ophthalmol; 2004 Mar; 137(3):445-52. PubMed ID: 15013866
[TBL] [Abstract][Full Text] [Related]
7. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
[TBL] [Abstract][Full Text] [Related]
8. [Screening of early color vision loss in diabetic patients].
Peduzzi M; Longanesi L; Ascari A; Cascione S; Galletti M; Roncaia R; Pacchioni C; Maione M
J Fr Ophtalmol; 1989; 12(11):791-6. PubMed ID: 2639899
[TBL] [Abstract][Full Text] [Related]
9. Spatio-temporal selectivity of loss of colour and luminance contrast sensitivity with multiple sclerosis and optic neuritis.
Flanagan P; Markulev C
Ophthalmic Physiol Opt; 2005 Jan; 25(1):57-65. PubMed ID: 15649184
[TBL] [Abstract][Full Text] [Related]
10. Male prevalence of acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy.
Ventura DF; Gualtieri M; Oliveira AG; Costa MF; Quiros P; Sadun F; de Negri AM; Salomão SR; Berezovsky A; Sherman J; Sadun AA; Carelli V
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2362-70. PubMed ID: 17460303
[TBL] [Abstract][Full Text] [Related]
11. Orientational contrast sensitivity and chromatic contrast thresholds in multiple sclerosis.
Jackson TL; Ong GL; Ripley LG
Am J Ophthalmol; 2004 Feb; 137(2):283-6. PubMed ID: 14962418
[TBL] [Abstract][Full Text] [Related]
12. Assessment of colour vision as a screening test for sight threatening diabetic retinopathy before loss of vision.
Ong GL; Ripley LG; Newsom RS; Casswell AG
Br J Ophthalmol; 2003 Jun; 87(6):747-52. PubMed ID: 12770974
[TBL] [Abstract][Full Text] [Related]
13. Color vision impairment in type 2 diabetes assessed by the D-15d test and the Cambridge Colour Test.
Feitosa-Santana C; Paramei GV; Nishi M; Gualtieri M; Costa MF; Ventura DF
Ophthalmic Physiol Opt; 2010 Sep; 30(5):717-23. PubMed ID: 20883359
[TBL] [Abstract][Full Text] [Related]
14. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
[TBL] [Abstract][Full Text] [Related]
15. Colour contrast sensitivity changes caused by peripheral retinal laser photocoagulation.
Canning CR; Strong N; Berninger TA; Arden GB
Eye (Lond); 1991; 5 ( Pt 3)():348-51. PubMed ID: 1955059
[TBL] [Abstract][Full Text] [Related]
16. Colour contrast thresholds are normal in functional amblyopia.
Mangelschots E; Beerlandt N; Janssens H; Spileers W
Eye (Lond); 1996; 10 ( Pt 4)():479-84. PubMed ID: 8944103
[TBL] [Abstract][Full Text] [Related]
17. Early detection of changes in visual function in diabetes mellitus.
Ismail GM; Whitaker D
Ophthalmic Physiol Opt; 1998 Jan; 18(1):3-12. PubMed ID: 9666905
[TBL] [Abstract][Full Text] [Related]
18. Macular ischaemia as a marker for nephropathy in diabetic retinopathy.
Shukla D; Kolluru CM; Singh J; John RK; Soman M; Gandhi B; Kim R; Perumalsamy N
Indian J Ophthalmol; 2004 Sep; 52(3):205-10. PubMed ID: 15510459
[TBL] [Abstract][Full Text] [Related]
19. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision.
Birch J; Hamilton AM
Trans Ophthalmol Soc U K (1962); 1981; 101(1):93-9. PubMed ID: 6192563
[TBL] [Abstract][Full Text] [Related]
20. Perceived color of hallucinations in the Charles Bonnet Syndrome is related to residual color contrast sensitivity.
Madill SA; Lascaratos G; Arden GB; ffytche DH
J Neuroophthalmol; 2009 Sep; 29(3):192-6. PubMed ID: 19726940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
